Evidence map›Paper›PMID 40868550›Full record

ArticleChildren (Basel, Switzerland)2025

A 10-Year Review of the Efficacy of Cranial Remolding Orthosis Treatment and Factors That Influence Outcomes for Infants with Isolated Deformational Plagiocephaly.

Anna L Trebilcock, Jill L Findley, J Suzanne Cherry, Jeffrey A Kasparek, Melody M Gordon, Stephen P Beals, Timothy R Littlefield

Abstract read
In one paragraph

Article in Children (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anna L TrebilcockCranial Technologies, Inc., Tempe, AZ 85284, USA.ORCID 0009-0006-0235-0604
Jill L FindleyCranial Technologies, Inc., Tempe, AZ 85284, USA.ORCID 0000-0001-8096-1060
J Suzanne CherryCranial Technologies, Inc., Tempe, AZ 85284, USA.
Jeffrey A KasparekCranial Technologies, Inc., Tempe, AZ 85284, USA.
Melody M GordonCranial Technologies, Inc., Tempe, AZ 85284, USA.
Stephen P BealsPhoenix Children's Hospital Center for Cleft and Craniofacial Care, Phoenix, AZ 85013, USA.
Timothy R LittlefieldCranial Technologies, Inc., Tempe, AZ 85284, USA.ORCID 0000-0002-8262-5519

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesThe purpose of this study was to examine the overall efficacy and treatment outcomes of CROs in the treatment of isolated deformational plagiocephaly and investigate the variables that influence treatment efficacy.

methodsThis was a 10-year retrospective review of N = 27, 990 infants with Isolated Deformational Plagiocephaly (IDP) who completed Cranial Remolding Orthosis (CRO) treatment between 3 and 18 months of age.

resultsThere was a significant overall mean change in CVAI(S) of -3.42 ± 0.011 (

conclusionsCROs are an effective, research-supported treatment for IDP. Pediatric health care providers and parents should be aware of the efficacy of CRO therapy across age groups and severity ratings, the risk factors that may influence CRO outcomes, and the benefits of an early referral at a young age.

Indexed as

cranial deformitycranial remolding orthosisCVAIdeformational plagiocephalyhelmet therapytreatment outcomes

Identifiers

PMID40868550
PMCPMC12384474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.